Vasodilating 1,1-di-(2-methoxycarbonyl-ethyl)-1,2,3,4,5,6,12,12b

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546 70, C07D47104, A61K 31445

Patent

active

041736427

ABSTRACT:
New pharmacologically active octahydro-indolo[2,3-a]quinolizine derivatives of the formula ##STR1## wherein Q is hydrogen or an A--CH.sub.2 --CH.sub.2 -- group and A is cyano or -COOR, wherein R is C.sub.1-6 alkyl are prepared by reacting 2,3,4,6,7,12-hexahydro-indolo[2,3-a]quinolizine with a compound of the formula CH.sub.2 .dbd.CH--A, and reducing the obtained hexahydroindolo[2,3-a] quinolizine derivative of the formula ##STR2##

REFERENCES:
patent: 3536725 (1970-10-01), Schvt
patent: 3830823 (1974-08-01), Castaigne
patent: 4033969 (1977-07-01), Sevenet et al.
patent: 4057551 (1977-11-01), Szantay et al.
patent: 4057551 (1977-11-01), Szantay et al.
patent: 4089856 (1978-05-01), Szantay et al.
Chemical Abstracts: 85:46624q, (1976) [Szantay et al., German Offen. 2,541,484, 4/15/76].
Imbert; T. et al., Bull. Soc. Chim. France, 1973 (No. 9-10), 2705-2709.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Vasodilating 1,1-di-(2-methoxycarbonyl-ethyl)-1,2,3,4,5,6,12,12b does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vasodilating 1,1-di-(2-methoxycarbonyl-ethyl)-1,2,3,4,5,6,12,12b, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vasodilating 1,1-di-(2-methoxycarbonyl-ethyl)-1,2,3,4,5,6,12,12b will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-462397

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.